RAC1 and RAC1B are overexpressed in CRC and associated with worse prognosis compared to tumors that do not have RAC1 or RAC1B overexpression, suggesting there is a role for these proteins in CRC biology and tumor progression [49]. This evidence concerns the gene RAC1 and colorectal carcinoma.